NEW YORK (GenomeWeb News) – GeneGo will use gene expression data from Entelos to develop its predictive toxicology modeling technology, GeneGo said.

Under the license agreement, GeneGo will use Entelos' DrugMatrix gene expression data to further develop its Functional Descriptor models.

Richard Brennan, GeneGo's director of toxicology, said that access to "a comprehensive, pharmacologically diverse and fully annotated compendium of gene expression data is critical to developing high-performance predictive models."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.